These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 17982720
1. A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan. Kawai N, Ikematsu H, Iwaki N, Kawamura K, Kawashima T, Kashiwagi S. J Infect Chemother; 2007 Oct; 13(5):314-9. PubMed ID: 17982720 [Abstract] [Full Text] [Related]
5. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H, Japanese Influenza Collaborative Study Group. J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344 [Abstract] [Full Text] [Related]
8. Influenza in Canada: 2006-2007 season. Reyes F, Aziz S, Li Y, Macey JF, Winchester B, Garner M, Huston P, King A. Can Commun Dis Rep; 2008 Mar; 34(3):1-25. PubMed ID: 18404807 [No Abstract] [Full Text] [Related]
9. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Matsuzaki Y, Mizuta K, Aoki Y, Suto A, Abiko C, Sanjoh K, Sugawara K, Takashita E, Itagaki T, Katsushima Y, Ujike M, Obuchi M, Odagiri T, Tashiro M. Virol J; 2010 Mar 05; 7():53. PubMed ID: 20202225 [Abstract] [Full Text] [Related]
10. The course of fever following influenza virus infection in children treated with oseltamivir. Suzuki E, Ichihara K. J Med Virol; 2008 Jun 05; 80(6):1065-71. PubMed ID: 18428131 [Abstract] [Full Text] [Related]
11. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan. Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, Kondo H, Suzuki Y, Saito K, Suzuki H. J Infect Chemother; 2012 Dec 05; 18(6):858-64. PubMed ID: 22644080 [Abstract] [Full Text] [Related]
15. Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics. Seo S, Englund JA, Nguyen JT, Pukrittayakamee S, Lindegardh N, Tarning J, Tambyah PA, Renaud C, Went GT, de Jong MD, Boeckh MJ. Antivir Ther; 2013 Sep 05; 18(3):377-86. PubMed ID: 23264438 [Abstract] [Full Text] [Related]
18. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. Kawai N, Ikematsu H, Iwaki N, Maeda T, Kanazawa H, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Nagai T, Horii S, Hirotsu N, Kashiwagi S. J Infect; 2008 Jan 05; 56(1):51-7. PubMed ID: 17936910 [Abstract] [Full Text] [Related]
20. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons. Kawai N, Ikematsu H, Tanaka O, Matsuura S, Maeda T, Yamauchi S, Hirotsu N, Nishimura M, Iwaki N, Kashiwagi S. J Infect Chemother; 2011 Jun 05; 17(3):375-81. PubMed ID: 21120678 [Abstract] [Full Text] [Related] Page: [Next] [New Search]